88573291

Information

• Trademark
• 88573291

• Source

• Serial Number

  88573291

• Registration Number

  6139784

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  August 09, 2019
  5 years ago

• Registration Date

  September 01, 2020
  4 years ago

• Transaction Date

  May 02, 2022
  2 years ago

• Status Date

  September 01, 2020
  4 years ago

• Published for Opposition Date

  June 16, 2020
  4 years ago

• Location Date

  September 01, 2020
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MAYES, LAURIE ANN

• Attorney Docket Number

  20199.25US02

  Attorney Name

  Sandra Epp Ryan

  Law Office Assigned Location Code

  L10

• Owners

  • KRINGLE PHARMA, INC

Case File Statements

• DM0000: The mark consists of four partial ovals appearing in blue.
• GS0051: Pharmaceutical and veterinary preparations for the treatment of liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer; sanitary preparations for medical use; central nervous system stimulants; hair growth stimulant; antipyretic analgesics; anti-epileptic pharmaceutical preparations; analeptics; hypnotic sedatives; general anesthetics; anti-motion sickness preparations; pharmaceutical preparations acting on the peripheral nervous system for treating solitary peripheral neuritis, polyneuritis monopoly, polyneuritis, radial nerve palsy, median nerve palsy, ulnar nerve palsy, peroneal nerve palsy, tibial nerve palsy, facial palsy, Bell palsy, oppressive neuropathy, acute intermittent porphyria, chronic inflammatory demyelinating neuropathy, trigeminal neuralgia, diabetic neuropathy, vitamin B deficiency, pellagra, beriberi, polyarthritis nodosa, systemic lupus erythematosus, carpal tunnel syndrome, tarsal tunnel syndrome, elbow tunnel syndrome, back pain, allodynia, pain of finger, numbness of finger, Guillain-Barre syndrome, Charcot-Marie-Tooth disease, Familial amyloid polyneuropathy, Addictive neuropathy, cancer neuropathy, Crow-Fukase syndrome, Postherpetic neuralgia, Polyneuropathy, Polyradiculitis, Neronopathy, Mononeuropathy, Multiple mononeuropathy, Plexopathy; local anesthetics; skeletal muscle relaxants; anhidrotics; autonomics in the nature of pharmaceutical preparations for treating heart conditions; antispasmodics; diaphoretics; pharmaceutical preparations acting on the sensory organs for treating eye illnesses and conditions; ophthalmic preparations; agents for otic and nasal use, namely, nasal spray preparations, medicated eye washes, eye drops, irrigating solutions for eye use; treatment preparations for treating eye infection, macular degeneration, retinopathy, rhinitis, and sinusitis; pharmaceutical antiallergic preparations; antihistaminics; cardiovascular treatment preparations; cardiotonics; antihypertensives; vasoconstrictors; capillary stabilizers, namely, pharmaceutical preparations for stabilizing capillaries; cerebral hemorrhage prophylactic preparations; antiarrhythmic preparations; diuretics; pharmaceutical preparations acting on respiratory organs for treating respiratory illnesses and conditions; respiratory stimulants; anti-cough drops; antitussive expectorants; pharmaceutical preparations acting on digestive organs for treating ulcers and digestive conditions; gastrointestinal cleaning agents; clysters in the nature of enema preparations; evacuants being purgatives; stomachics in the nature of medicinal tonics that assist in digestion and digestives for pharmaceutical purposes; pharmaceutical preparations for oral use for preventing dental caries, and for treating and preventing oral inflammation; emetics; pharmaceutical preparations for dental purposes for treating and preventing gingivostomatitis, alveolar abscess, and alveoloclasia; antacids; antiemetics; castor oil for medical purposes; cholagogues; hormones for medical purposes; thyroid and para-thyroid hormone preparations; mixed hormone preparations; estrogen preparations; pancreas hormone preparations; salivary gland hormone preparations; androgen preparations; pituitary hormone preparations; adrenal hormone preparations; pharmaceutical preparations acting on uro-genital and anal organs for treating urinary and anal gland related illnesses and conditions; oxytocics; anti-hemorrhoidal preparations; emmenagogues; contraceptive preparations; medicated skin care preparations; pharmaceutical preparations for treating purulence; anti-dermoinfectives; antimicrobials for dermatologic use; astringents for medical purposes; anti-inflammatory agents; analgesics; anti-itching ointment; talcum powder for medical purposes; medicated baby oils; medicated baby powders; medicated bath preparations; vitamin preparations for medical purposes; cod-liver oil drops for medical purposes; mixed vitamin preparations for medical purposes; vitamin A preparations for medical purposes; vitamin C preparations for medical purposes; vitamin D preparations for medical purposes; vitamin B preparations for medical purposes; multi-vitamin preparations for medical purposes; amino acid preparations for medical purposes; threonine preparations; tryptophane preparations; methionine preparations; lysine preparations; royal jelly for medical purposes; calcium supplements for medical purposes; chondroitin preparations for medical purposes; protein supplements and amino acid preparations for medical purposes; saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, and lupus erhthematosus; mineral preparations for medical use; anticoagulants; blood substitutes for human and veterinary use; blood plasma; hemostatics for medical purposes; pharmaceutical preparations affecting metabolism; antidotes; enzyme preparations for medical purposes; lactagogues; lipotropic factor preparations; pharmaceutical preparations for the treatment of habitual intoxication; pharmaceutical preparations for activating cellular function; tumor suppressing agents; anti-cancer preparations; anti-sarcoma preparations; pharmaceutical preparations for treating physically caused lesions; pharmaceutical preparations for treating heatstroke; radiation sickness treating drugs; pharmaceutical preparations for treating chemically caused disorders, namely, for treating chemical burns, side effects of anticancer drugs, and side effects of immunosuppresants; chlorine-detoxication preparations for medical purposes; arsenic-detoxication preparations for medical purposes; benzol-detoxication preparations for medical purposes; antibiotic preparations; erythromycin preparations; chloramphenicol preparations; colistin-polymixin preparations; sarkomycin preparations; streptomycin preparations; thiolutin preparations; tetracycline preparations; trichomycin preparations; mixed antibiotic preparations; penicillin preparations; chemotherapeutics; antisyphilitics; antituberculous preparations; sulfonamide preparations; antileprotic preparations; biological preparations for medical purposes, namely, biological tissue grafts; antitoxic sera; antitoxins; mixed biological preparations for medical purposes for the treatment of cancer; preparations for biological tests for medical purposes, namely, medical diagnostic reagents for testing of body fluids; toxoids, namely, vaccines against the flu; vaccines; preparations for destroying parasites; anthelmintics; odor neutralizing preparations for use on hard surfaces that have had contact with odorous pharmaceuticals; diagnostic preparations for medical use; x-ray contrast agents; diagnostic reagents for medical use; diagnostic media for bacteriological cultures for medical use; radio isotope markers for therapeutic or diagnostic use; opium alkaloid preparations; prescription synthetic narcotics; coca alkaloid preparations; mosquito-repellent incenses; germicides and fungicides; rodenticides; insecticides; fumigants; herbicides, namely, weedkillers; insect-repellents; antiseptics
• CC0000: The color(s) blue is/are claimed as a feature of the mark.
• GS0421: Testing, inspection or research of pharmaceuticals and genetics; medical research; consultancy and providing testing, inspection and research information services in the field of testing, inspection or research of pharmaceuticals and genetics; consultancy and providing research information services in the field of medical research; providing medical research and scientific research information and advice in the fields of pharmaceuticals and genetics

Case File Event Statements

• 5/2/2022 - 2 years ago

  21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 5/2/2022 - 2 years ago

  20 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 5/2/2022 - 2 years ago

  19 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 5/2/2022 - 2 years ago

  18 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 5/2/2022 - 2 years ago

  17 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 9/1/2020 - 4 years ago

  16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/16/2020 - 4 years ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/16/2020 - 4 years ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/27/2020 - 4 years ago

  13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/11/2020 - 4 years ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/8/2020 - 4 years ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/8/2020 - 4 years ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/5/2020 - 4 years ago

  9 - ASSIGNED TO LIE Type: ALIE

• 4/30/2020 - 4 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/13/2019 - 4 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 11/13/2019 - 4 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 11/13/2019 - 4 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/7/2019 - 4 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 8/27/2019 - 5 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 8/26/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 8/13/2019 - 5 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP